Osimertinib was the first drug to be approved for adjuvant treatment after complete tumor resection in adults with stage IB
Continue reading »
mypharmacynews.com
Home »
Osimertinib was the first drug to be approved for adjuvant treatment after complete tumor resection in adults with stage IB
Continue reading »Scientists at St. Jude Children’s Research Hospital have shown that a class of drugs they pioneered has the potential to
Continue reading »Researchers from Tokyo Medical and Dental University (TMDU) identify a small RNA molecule with the potential to help slow cartilage
Continue reading »Like amyloid plaque, the genetic variant APOE4 has long been associated with Alzheimer’s disease, but still little is known about
Continue reading »A lot about the human brain and its intricacies continues to remain a mystery. With the advancement of neurobiology, the
Continue reading »For certain blood cancers, such as acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS), deciding whether patients need an aggressive
Continue reading »West Virginia University scientists used MRI scans to show what happens when ultrasound waves target a specific area of Alzheimer’s
Continue reading »Huntington’s disease is caused by a mutation in the Huntingtin gene (HTT), which appears in adults and features motor, cognitive
Continue reading »An “immuno-storm chip” developed by University of Queensland researchers could diagnose cancer and COVID-19 patients at risk of a potentially
Continue reading »SORLA is a protein trafficking receptor that has been mainly studied in neurons, but it also plays a role in
Continue reading »